Madison, WI — (BUSINESS WIRE) — NeuroPointDX today announced the appointment of Marvin Natowicz, M.D., Ph.D., medical geneticist
Read moreNew biomarkers detected in 1,100 subject study accurately identify specific subtypes of ASD related to abnormalities in
Read moreNeuroPointDX has validated 12 metabolic subtypes of autism spectrum disorder. The diagnostic blood test for ASD will be
Read moreIn collaboration with the Greater Madison Chamber of Commerce, the Wisconsin State Journal produced a special section to
Read moreDr. Driesmann, a leader in the diagnostics industry, will guide Stemina’s commercialization strategy. Read the full press release.
Read moreMetabolic Profiling of the Children’s Autism Metabolome Project (CAMP) NeuroPointDX is conducting a research study called Children’s Autism
Read moreTogether, Ovid and NeuroPointDX will use metabolomics data to better understand the rare neuro-genetic disorder known as Angelman
Read moreStemina’s CEO, Beth Donley, will deliver the welcome remarks at the 64th Annual Greater Madison Chamber of Commerce
Read moreThe International Meeting for Autism Research (IMFAR) will be held in Baltimore, Maryland May 11-14. Visit the Saturday
Read moreA University of Wisconsin—Madison spinoff is screening blood samples in an effort to develop a biologically based method
Read more